Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Alzheimer Disease
In brief
This study will compare atomoxetine to placebo when taken with current standard Alzheimer's Disease medications. The treatment will take approximately 6 months and it is hypothesized atomoxetine will significantly improve cognitive performance as compared to placebo.
Key facts
- Study ID
- NCT00191009
- Run by
- Eli Lilly and Company
- People needed
- 124
- Starts
- 2003-10-01
- Expected to finish
- 2006-01-01
- Last updated by the study team
- 2007-11-06
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient presents with Alzheimer's Disease based on clinical history.
- Patient must have a Mini Mental Status Score between 10 and 26.
- Patient must have a reliable caregiver in frequent or daily contact with the patient.
- Patient must be currently treated with and on a stable dose of a standard Alzheimer's drug treatment for at least 3 months.
You may not qualify if…
- Patients who are receiving pharmacologic treatments (other than a cholinesterase inhibitor or memantine) for Alzheimer's Disease.
- Patients who have a history in the past 5 years or any current evidence of major psychiatric illness.
- Patients who have narrow angle glaucoma.
- Patients who are experiencing clinically significant urinary hesitancy or retention as assessed by a physician.
Where it is running
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Sherman Oaks, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Rochester, New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Wichita Falls, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.